Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dierk Thomas

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
Biochimica Et Biophysica Acta|October 4, 2011
Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channelsJakob Gierten, David Hassel, Patrick A Schweizer, et al.
Biochimica Et Biophysica Acta|January 19, 2011
Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variabilityParwez Aidery, Jana Kisselbach, Patrick A Schweizer, et al.
European Journal of Pharmacology|September 28, 2013
Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 16, 2014
Rescue renal sympathetic denervation in a patient with ventricular electrical storm refractory to endo- and epicardial catheter ablation: response to comments by Huang et alEberhard P Scholz, Philip Raake, Dierk Thomas, et al.
Plos One|March 17, 2015
Atrial fibrillation complicated by heart failure induces distinct remodeling of calcium cycling proteinsPatrick Lugenbiel, Fabian Wenz, Katharina Govorov, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 13, 2018
New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K<sub>2P</sub>3.1 (TASK-1) ChannelsConstanze Schmidt, Felix Wiedmann, Anne-Rike Gaubatz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 14, 2012
Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Gene|September 25, 2012
Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1Parwez Aidery, Jana Kisselbach, Patrick A Schweizer, et al.
Life Sciences|August 23, 2012
Enhancement of K2P2.1 (TREK1) background currents expressed in Xenopus oocytes by voltage-gated K+ channel β subunitsJana Kisselbach, Patrick A Schweizer, Rüdiger Gerstberger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 18, 2020
Electrophysiological effects of non-vitamin K antagonist oral anticoagulants on atrial repolarizing potassium channelsFelix Wiedmann, Daniel Schlund, Manuel Kraft, et al.
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
Biochimica Et Biophysica Acta|October 4, 2011
Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channelsJakob Gierten, David Hassel, Patrick A Schweizer, et al.
Biochimica Et Biophysica Acta|January 19, 2011
Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variabilityParwez Aidery, Jana Kisselbach, Patrick A Schweizer, et al.
European Journal of Pharmacology|September 28, 2013
Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 16, 2014
Rescue renal sympathetic denervation in a patient with ventricular electrical storm refractory to endo- and epicardial catheter ablation: response to comments by Huang et alEberhard P Scholz, Philip Raake, Dierk Thomas, et al.
Plos One|March 17, 2015
Atrial fibrillation complicated by heart failure induces distinct remodeling of calcium cycling proteinsPatrick Lugenbiel, Fabian Wenz, Katharina Govorov, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 13, 2018
New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K<sub>2P</sub>3.1 (TASK-1) ChannelsConstanze Schmidt, Felix Wiedmann, Anne-Rike Gaubatz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 14, 2012
Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Gene|September 25, 2012
Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1Parwez Aidery, Jana Kisselbach, Patrick A Schweizer, et al.
Life Sciences|August 23, 2012
Enhancement of K2P2.1 (TREK1) background currents expressed in Xenopus oocytes by voltage-gated K+ channel β subunitsJana Kisselbach, Patrick A Schweizer, Rüdiger Gerstberger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 18, 2020
Electrophysiological effects of non-vitamin K antagonist oral anticoagulants on atrial repolarizing potassium channelsFelix Wiedmann, Daniel Schlund, Manuel Kraft, et al.
Pageof 22